Yahoo
Stockholm - Delayed Quote SEK

Getinge AB (publ) (GETI-B.ST)

277.70 +4.30 (+1.57%)
At close: October 30 at 12:59:56 PM GMT+1
Chart Range Bar
Loading chart for GETI-B.ST
  • Previous Close 273.40
  • Open 274.00
  • Bid 277.10 x --
  • Ask 277.30 x --
  • Day's Range 273.40 - 280.70
  • 52 Week Range 175.90 - 280.70
  • Volume 384,827
  • Avg. Volume 536,993
  • Market Cap (intraday) 75.637B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 26.73
  • EPS (TTM) 10.39
  • Earnings Date Oct 21, 2026
  • Forward Dividend & Yield 4.75 (1.71%)
  • Ex-Dividend Date Apr 22, 2026
  • 1y Target Est 272.91

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

www.getinge.com

11,847

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

GETI-B.ST
30.04%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

GETI-B.ST
26.45%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

GETI-B.ST
51.55%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

GETI-B.ST
20.19%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 8.45B
Earnings 719M
Profit Margin 8.51%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
8B
10B
6.0%
7.0%
8.0%
9.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

193.00 Low
272.91 Average
277.70 Current
320.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.21%

  • Return on Assets (ttm)

    5.29%

  • Return on Equity (ttm)

    9.14%

  • Revenue (ttm)

    34.46B

  • Net Income Avi to Common (ttm)

    2.83B

  • Diluted EPS (ttm)

    10.39

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.16B

  • Total Debt/Equity (mrq)

    34.34%

  • Levered Free Cash Flow (ttm)

    3.4B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: